Skip to main content
. 2021 Apr;12(Suppl 1):S5–S17. doi: 10.21037/jgo-20-129

Table 7. Four-year survival probability (% ±SE) in HIPEC and control groups.

Survival Control group HIPEC group Plog-rank
Overall survival 34.6±6.6 47.1±6.1 0.2
Cancer-specific survival 36.7±6.9 51.8±6.3 0.09
Progression-free survival 19.6±5.6 47.1±6.3 <0.001
Dissemination-free survival 22.7±6.0 51.9±6.3 <0.001
Metastases-free survival 31.1±6.5 42.6±6.0 0.2

HIPEC, hyperthermic intraperitoneal chemotherapy; SE, standard error.